Twitxy
Saved
@EASLedu's profile picture
View on X

EASL Education

Verified account This account is verified. Learn more

@EASLedu

@EASLedu brings you the latest on #liver research & education. Visit #EASLCampus
-----------------
EASL does not express any political opinion.
RT ≠ endorsement
EASLCampus.eu Joined January 2016
718 Following 14K Followers 20K Posts

Latest posts 5

Pinned post

EASL Education Verified account @EASLedu
🔬 #HCC without cirrhosis or underlying liver disease, what does that change?🧐

Now available on demand, this #EASLMTB uses a challenging case to explore tumour biology, early recurrence, adjuvant therapy, and the role of liver transplantation in non-cirrhotic HCC.

Watch the full discussion now.
📺easlcampus.eu/webinars/easl-…

@FRPonziani @BernharScheiner @TZ_Hirsch @LynnSavic @FrancqueSven @MattiasMandorf1
EASL Education Verified account @EASLedu
Register for the #EASLDeepDive tonight!
Explore AI-driven trial design with a focus on:
👉Patient selection
👉Digital twins,
👉Use of real-world data to strengthen clinical evidence

Discover the opportunities, scientific challenges, and limitations of AI in clinical research.
🖋️easl-eu.zoom.us/webinar/regist…

@kenlkehl @FaisalLab @AnalogAldo @RaqPerezLopez
@aapedrol @FrancqueSven
EASL Education Verified account @EASLedu
From promise to practice: Is AI ready to reshape clinical trials?🧐

Join us next week for an evidence-based discussion at the next #EASLDeepDive!

More information below👇

@kenlkehl @FaisalLab @AnalogAldo @RaqPerezLopez @aapedrol @FrancqueSven
#LiverX
EASLnews Verified account @EASLnews Oct 27
From optimising patient stratification to simulating treatment responses using digital twins, AI offers new possibilities for clinical research.

Register for the next EASL DeepDive to examine the evidence behind these approaches, their clinical applications, and their limitations.

📅 Wedneday, 4 November, 18:00 CET
Register here: easl-eu.zoom.us/webinar/regist…
The image is a promotional banner for an EASL DeepDive event titled "AI-Enabled Clinical Trials: Opportunities, Evidence and Oversight" on 4 November at 18:00 CET. It features four circular headshots of individuals labeled as Kenneth Kehl, Olivier Gevaert, Anna Pedrola, and Raquel Perez-Lopez. The banner includes a call-to-action button that reads, "Register now!
View quoted post on X
EASL Education Verified account @EASLedu
🎙️ Tune in for a thought-provoking discussion on one of the key challenges in #HCC care.

Plenty of questions, not always straightforward answers!🧐

More info below 👇

#TalkLiverToMe #LiverX
EASLnews Verified account @EASLnews Oct 28
📊 How should HCC surveillance evolve as risk profiles change?

This new episode of #TalkLiverToMe explores the evidence behind patient selection, surveillance timing and modality choice, while addressing persistent variation between guidelines and the limitations of current surveillance strategies.

Now on EASL Campus: easlcampus.eu/tltm/episode-20
Also on Spotify: open.spotify.com/episode/5THbZ6…
and Apple Podcasts: podcasts.apple.com/ch/podcast/tal…
The image is an announcement for a talk titled "Hepatocellular Carcinoma: Who to screen, when, and how?" It's hosted by Mattias Mandorfer with Peter Jepsen and Amit Singal. The background features hexagons and the logos for "Talk to Me Liver" and EASL, The Home of Hepatology. The text "Available now!" is displayed in the top left corner.
View quoted post on X
EASL Education Verified account @EASLedu
#LiverX, how would you approach this case? 🤔

👉#HCC without cirrhosis.
👉Early recurrence.
👉Difficult treatment decisions.

There's still time to register for the #EASLMTB happening tonight and join the discussion!

More information below👇

@FRPonziani @BernharScheiner @TZ_Hirsch @LynnSavic @FrancqueSven @MattiasMandorf1
EASLnews Verified account @EASLnews Oct 22
🩺 One complex case. Key clinical questions. Expert insights.

Explore the case of a 44-year-old woman with HCC arising without cirrhosis or underlying liver disease. From surgical resection and recurrence management to liver transplantation, discover the clinical challenges and treatment considerations discussed by our experts.

🔬 Join our upcoming Molecular Tumour Board, next Wednesday!

Register now: easl-eu.zoom.us/webinar/regist…
EASL Molecular Tumour Board poster for "HCC in non-cirrhotic liver" event on Wednesday, 28 October 2026, from 18:00-19:00 CET. Features headshots of Francesca Romana Ponziani, Bernhard Scheiner, Theo Hirsch, Christian Toso, Michail Doukas, and Lynn Jeanette Savic. Includes "Register now!" prompt. Background has a pink, organic texture.
View quoted post on X